Market Research Logo

Seasonal Influenza - Pipeline Review, H2 2015

Seasonal Influenza - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Seasonal Influenza - Pipeline Review, H2 2015’, provides an overview of the Seasonal Influenza’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Seasonal Influenza, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seasonal Influenza and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Seasonal Influenza
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Seasonal Influenza and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Seasonal Influenza products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Seasonal Influenza pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Seasonal Influenza
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Seasonal Influenza pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Seasonal Influenza Overview
Therapeutics Development
Pipeline Products for Seasonal Influenza - Overview
Pipeline Products for Seasonal Influenza - Comparative Analysis
Seasonal Influenza - Therapeutics under Development by Companies
Seasonal Influenza - Therapeutics under Investigation by Universities/Institutes
Seasonal Influenza - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Seasonal Influenza - Products under Development by Companies
Seasonal Influenza - Products under Investigation by Universities/Institutes
Seasonal Influenza - Companies Involved in Therapeutics Development
AIMM Therapeutics B.V.
Altimmune, Inc.
AltraVax Inc.
AmVac AG
Big DNA Ltd.
BioDiem Ltd
BiondVax Pharmaceuticals Ltd.
Celltrion, Inc.
Cilian AG
Codagenix, Inc.
ContraFect Corporation
Crucell N.V.
CSL Limited
Daiichi Sankyo Company, Limited
Enyo Pharma S.A.S.
Eurocine Vaccines AB
FluGen, Inc.
GlaxoSmithKline Plc
Hemispherx Biopharma, Inc.
Imaxio SA
Johnson & Johnson
Liquidia Technologies, Inc.
Medicago Inc.
Merck & Co., Inc.
Novavax, Inc.
OPKO Health, Inc.
PeptiVir, Inc.
Protein Sciences Corporation
TechnoVax, Inc.
Theraclone Sciences, Inc.
Touchlight Genetics Limited
TSRL, Inc.
Vaxart, Inc.
Vaxine Pty Ltd
VaxInnate Corporation
Vivaldi Biosciences Inc.
Zydus Cadila Healthcare Limited
Seasonal Influenza - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
A-06 - Drug Profile
Alferon LDO - Drug Profile
AMV-401 - Drug Profile
BDNA-002 - Drug Profile
Bispecific Monoclonal Antibody to Inhibit Hemagglutinin for Seasonal and Pandemic Influenza - Drug Profile
CF-404 - Drug Profile
CiFlu - Drug Profile
CR-8020 - Drug Profile
CTP-25 - Drug Profile
CTP-27 - Drug Profile
FluCell - Drug Profile
FP-01 - Drug Profile
IKT-041 - Drug Profile
IMX-313-IF - Drug Profile
Influ-nRNA - Drug Profile
influenza (quadrivalent) virus like particle vaccine - Drug Profile
influenza (split virion, trivalent) vaccine - Drug Profile
influenza (trivalent) vaccine - Drug Profile
influenza (trivalent) virus like particle vaccine - Drug Profile
influenza [serotype B] vaccine - Drug Profile
influenza [strain B/yamagata] (monovalent) vaccine - Drug Profile
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine - Drug Profile
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine - Drug Profile
influenza [strains A/H1N1 + A/H3N2 + B] vaccine - Drug Profile
influenza [Strains H1N1, H3N2, influenza B] (quadrivalent) virus like particle vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
JNJ-872 - Drug Profile
LIQ-001 - Drug Profile
M-001 - Drug Profile
MER-4101 - Drug Profile
Monoclonal Antibodies to Inhibit Hemagglutinin for Seasonal Influenza and Pandemic Influenza - Drug Profile
NB-1008 - Drug Profile
PVI-1000 - Drug Profile
respiratory syncytical virus + influenza vaccine - Drug Profile
seasonal influenza (quadrivalent) vaccine - Drug Profile
seasonal influenza (quadrivalent) vaccine - Drug Profile
seasonal influenza (trivalent) vaccine - Drug Profile
seasonal influenza (trivalent) vaccine - Drug Profile
seasonal influenza (trivalent, split virion) vaccine - Drug Profile
seasonal influenza vaccine - Drug Profile
seasonal influenza vaccine - Drug Profile
seasonal influenza vaccine - Drug Profile
Small Molecule to Inhibit Neuraminidase for Influenza - Drug Profile
Small Molecules for Influenza - Drug Profile
Small Molecules to Activate Sirtuin for Influenza - Drug Profile
TSR-026 - Drug Profile
TSR-462 - Drug Profile
TVX-001 - Drug Profile
VAX-2012Q - Drug Profile
VB126 LAIV - Drug Profile
VH-244 - Drug Profile
VN-100 - Drug Profile
VXAA-1.1 - Drug Profile
Seasonal Influenza - Recent Pipeline Updates
Seasonal Influenza - Dormant Projects
Seasonal Influenza - Discontinued Products
Seasonal Influenza - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Seasonal Influenza, H2 2015
Number of Products under Development for Seasonal Influenza - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd..1)
Number of Products under Development by Companies, H2 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Development by Companies, H2 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H2 2015
Seasonal Influenza - Pipeline by AIMM Therapeutics B.V., H2 2015
Seasonal Influenza - Pipeline by Altimmune, Inc., H2 2015
Seasonal Influenza - Pipeline by AltraVax Inc., H2 2015
Seasonal Influenza - Pipeline by AmVac AG, H2 2015
Seasonal Influenza - Pipeline by Big DNA Ltd., H2 2015
Seasonal Influenza - Pipeline by BioDiem Ltd, H2 2015
Seasonal Influenza - Pipeline by BiondVax Pharmaceuticals Ltd., H2 2015
Seasonal Influenza - Pipeline by Celltrion, Inc., H2 2015
Seasonal Influenza - Pipeline by Cilian AG, H2 2015
Seasonal Influenza - Pipeline by Codagenix, Inc., H2 2015
Seasonal Influenza - Pipeline by ContraFect Corporation, H2 2015
Seasonal Influenza - Pipeline by Crucell N.V., H2 2015
Seasonal Influenza - Pipeline by CSL Limited, H2 2015
Seasonal Influenza - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
Seasonal Influenza - Pipeline by Enyo Pharma S.A.S., H2 2015
Seasonal Influenza - Pipeline by Eurocine Vaccines AB, H2 2015
Seasonal Influenza - Pipeline by FluGen, Inc., H2 2015
Seasonal Influenza - Pipeline by GlaxoSmithKline Plc, H2 2015
Seasonal Influenza - Pipeline by Hemispherx Biopharma, Inc., H2 2015
Seasonal Influenza - Pipeline by Imaxio SA, H2 2015
Seasonal Influenza - Pipeline by Johnson & Johnson, H2 2015
Seasonal Influenza - Pipeline by Liquidia Technologies, Inc., H2 2015
Seasonal Influenza - Pipeline by Medicago Inc., H2 2015
Seasonal Influenza - Pipeline by Merck & Co., Inc., H2 2015
Seasonal Influenza - Pipeline by Novavax, Inc., H2 2015
Seasonal Influenza - Pipeline by OPKO Health, Inc., H2 2015
Seasonal Influenza - Pipeline by PeptiVir, Inc., H2 2015
Seasonal Influenza - Pipeline by Protein Sciences Corporation, H2 2015
Seasonal Influenza - Pipeline by TechnoVax, Inc., H2 2015
Seasonal Influenza - Pipeline by Theraclone Sciences, Inc., H2 2015
Seasonal Influenza - Pipeline by Touchlight Genetics Limited, H2 2015
Seasonal Influenza - Pipeline by TSRL, Inc., H2 2015
Seasonal Influenza - Pipeline by Vaxart, Inc., H2 2015
Seasonal Influenza - Pipeline by Vaxine Pty Ltd, H2 2015
Seasonal Influenza - Pipeline by VaxInnate Corporation, H2 2015
Seasonal Influenza - Pipeline by Vivaldi Biosciences Inc., H2 2015
Seasonal Influenza - Pipeline by Zydus Cadila Healthcare Limited, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Seasonal Influenza Therapeutics - Recent Pipeline Updates, H2 2015
Seasonal Influenza - Dormant Projects, H2 2015
Seasonal Influenza - Dormant Projects (Contd..1), H2 2015
Seasonal Influenza - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Seasonal Influenza, H2 2015
Number of Products under Development for Seasonal Influenza - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report